Cltx’s tumor selectivity was originally attributed to binding of chloride ion channels (CLC-3) in glioma cells, and functionally, Cltx inhibited migration and invasion by glioma cells in a dose dependent manner [7]. The gene discussed is CLCN3; the disease is glioma.